Jim Simons
EVOK

Jim Simons’s Evoke Pharma EVOK Stock Holding History

Jim Simons’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-932
Closed -$21K – 4022
2023
Q1 		$21K Buy
+932
New +$36.5K ﹤0.01% 3812
2022
Q2 		– Sell
-196
Closed -$14K – 4316
2022
Q1 		$14K Sell
196
-120
-38% -$9.57K ﹤0.01% 4018
2021
Q4 		$25K Buy
+316
New +$44.2K ﹤0.01% 3833
2021
Q1 		– Sell
-1,301
Closed -$483K – 3428
2020
Q4 		$483K Buy
1,301
+1,146
+739% +$591K ﹤0.01% 2833
2020
Q3 		$105K Buy
+155
New +$98.9K ﹤0.01% 3211
2019
Q3 		– Sell
-149
Closed -$13K – 3492
2019
Q2 		$13K Buy
+149
New +$14.8K ﹤0.01% 3502
2016
Q4 		– Sell
-833
Closed -$271K – 3298
2016
Q3 		$271K Buy
833
+702
+536% +$321K ﹤0.01% 2988
2016
Q2 		$129K Buy
+131
New +$103K ﹤0.01% 3126
2015
Q4 		– Sell
-92
Closed -$38K – 3313
2015
Q3 		$38K Buy
92
+2
+2% +$1.26K ﹤0.01% 3093
2015
Q2 		$68K Buy
+90
New +$76.6K ﹤0.01% 3134

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Jim Simons's EVOK Position: Q2 2023 in Review

Jim Simons sold out of Evoke Pharma (EVOK) in Q2 2023, closing a stake of 932 shares — an estimated $21K sold.

Jim Simons first reported a position in EVOK in Q2 2015 and held it in 10 quarters. The position peaked at $483K in Q4 2020. 10 funds tracked by Wall St. Rank hold EVOK as of Q2 2023.

  • Jim Simons reported no remaining Evoke Pharma position as of Q2 2023 after selling out during the quarter.
  • Jim Simons sold 932 Evoke Pharma shares in Q2 2023, an estimated $21K.
  • Jim Simons first reported a position in Evoke Pharma in Q2 2015 and held it in 10 quarters.
  • Jim Simons's Evoke Pharma position peaked at $483K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.